510(k) K242693
K242693 is an FDA 510(k) premarket notification submitted by Deka Research and Development Corporation for the device "DEKA Infusion System, DEKA Administration Set". The FDA issued a decision of Substantially Equivalent on October 7, 2024. The device falls under product code LDR (Controller, Infusion, Intravascular, Electronic), a Class II device regulated under 21 CFR 880.5725.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 7, 2024
- Date Received
- September 9, 2024
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Controller, Infusion, Intravascular, Electronic
- Device Class
- Class II
- Regulation Number
- 880.5725
- Review Panel
- HO
- Submission Type